Valbiotis (XPAR:ALVAL) FFO


XPAR:ALVAL Valbiotis SA XPAR:ALVAL
55 GF Score
Price €0.75
GF Value €1.49
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Valbiotis FFO?

FFO (Funds from operations) only applies to REITs.

XPAR:ALVAL
55GF Score
Valbiotis SA XPAR:ALVAL
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Valbiotis (XPAR:ALVAL) Overvalued in 2026?

Based on GuruFocus' analysis, Valbiotis stock appears to be undervalued. The current stock price of €0.75 is trading 50% below its estimated GF Value™ of €1.49. GuruFocus considers Valbiotis to be Possible Value Trap.

Key valuation signals for XPAR:ALVAL:

  • FFO:
  • GF Value™: €1.49 vs. price of €0.75 (50% below fair value)
  • GF Score™: 55/100 with 6 warning signs

No single metric tells the full story. See the XPAR:ALVAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Valbiotis Business Description

Other Exchanges 8JD:Germany
Address 12F rue Paul VATINE, Perigny, La Rochelle, FRA, 17180
Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.
55GF Score

Get the complete analysis for XPAR:ALVAL

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.75
Price
€1.49
GF Value